v3.25.4

Financial Instruments and Significant Concentrations | 6 Months Ended
--- | ---
Dec. 31, 2025
Financial Instruments and Significant Concentrations |
Financial Instruments and Significant Concentrations | Note 13 — Financial Instruments and Significant Concentrations Fair Value Measurements Fair value is defined as the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. When determining fair value, the Company considers the principal or most advantageous market in which it transacts and considers assumptions that market participants would use when pricing the asset or liability. The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: Level 1—Quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. Level 2—Other than quoted prices included in Level 1 that are observable for the asset and liability, either directly or indirectly through market corroboration, for substantially the full term of the asset or liability. Level 3—Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any market activity for the asset or liability at the measurement date. The following tables present information about the Company’s financial assets measured at fair value on a recurring basis and indicates the fair value hierarchy classification as of December 31, 2025 and June 30, 2025 (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​
​ | ​ | Fair Value Measurement of Assets as of December 31, 2025
​ | ​ | Total | ​ | Level 1 | ​ | Level 2 | ​ | Level 3
Cash and cash equivalents: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Money market funds | ​ | $ | 8,126 | ​ | $ | 8,126 | ​ | $ | — | ​ | $ | —
Marketable debt securities: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Corporate commercial paper | ​ | ​ | 40,452 | ​ | ​ | — | ​ | ​ | 40,452 | ​ | ​ | —
U.S. Government agencies | ​ | ​ | 1,270 | ​ | ​ | — | ​ | ​ | 1,270 | ​ | ​ | —
U.S. Government treasuries | ​ | ​ | 1,750 | ​ | ​ | — | ​ | ​ | 1,750 | ​ | ​ | —
Corporate notes and bonds | ​ | ​ | 77,522 | ​ | ​ | — | ​ | ​ | 77,522 | ​ | ​ | —
Total | ​ | $ | 129,120 | ​ | $ | 8,126 | ​ | $ | 120,994 | ​ | $ | —
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Fair Value Measurement of Assets as of June 30, 2025
​ | ​ | Total | ​ | Level 1 | ​ | Level 2 | ​ | Level 3
Cash and cash equivalents: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Money market funds | ​ | $ | 86,059 | ​ | $ | 86,059 | ​ | $ | — | ​ | $ | —
Corporate commercial paper | ​ | ​ | 1,000 | ​ | ​ | — | ​ | ​ | 1,000 | ​ | ​ | —
U.S. Government treasuries | ​ | ​ | 1,996 | ​ | ​ | — | ​ | ​ | 1,996 | ​ | ​ | —
Marketable debt securities: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Corporate commercial paper | ​ | ​ | 16,588 | ​ | ​ | — | ​ | ​ | 16,588 | ​ | ​ | —
U.S. Government agencies | ​ | ​ | 5,445 | ​ | ​ | — | ​ | ​ | 5,445 | ​ | ​ | —
U.S. Government treasuries | ​ | ​ | 1,484 | ​ | ​ | — | ​ | ​ | 1,484 | ​ | ​ | —
Corporate notes and bonds | ​ | ​ | 50,234 | ​ | ​ | — | ​ | ​ | 50,234 | ​ | ​ | —
Total | ​ | $ | 162,806 | ​ | $ | 86,059 | ​ | $ | 76,747 | ​ | $ | —
​ Marketable debt securities classified as Level 2 within the valuation hierarchy generally consist of corporate bonds, commercial paper, and U.S. government agency securities. The Company determines the fair value of marketable debt securities based upon valuations obtained from third-party pricing sources. Except for the amounts shown in the tables above, the Company did not have any other assets measured at fair value on a recurring basis as of December 31, 2025 and June 30, 2025. The Company’s embedded derivative liability discussed in Note 6 is classified under Level 3 of the fair value hierarchy and is required to be measured and recorded at fair value on a recurring basis. Fair value is determined based on management’s assessment of the probability and timing of occurrence for the Exit Events discussed in Note 6 using a discount rate equal to the historical effective interest rate under the Loan Agreement. ​ The following table sets forth changes in the fair value of the Company’s embedded derivative liability for which fair value was determined on a recurring basis for the six months ended December 31, 2025 and 2024 (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​
​ | 2025 | ​ | 2024
Fair value, beginning of period | $ | 468 | ​ | $ | 468
Changes in fair value | ​ | 15 | ​ | ​ | 9
Fair value, end of period | $ | 483 | ​ | $ | 477
​ Except for the embedded derivative liability, the Company did not have any other liabilities measured at fair value on a recurring basis as of December 31, 2025 and June 30, 2025. Due to the relatively short maturity of the respective instruments, the fair value of cash, accounts payable, and accrued liabilities approximated their carrying values as of December 31, 2025 and June 30, 2025. The Company’s policy is to recognize asset or liability transfers among Level 1, Level 2 and Level 3 as of the actual date of the events or change in circumstances that caused the transfer. During the six months ended December 31, 2025 and 2024, the Company did not have any transfers of its assets or liabilities between levels of the fair value hierarchy. Significant Concentrations Financial instruments that subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents and investments in marketable debt securities. The Company maintains cash in demand deposit accounts at a high-quality financial institution. As of and for the six months ended December 31, 2025 and 2024, cash deposits have exceeded the amount of insurance provided on such deposits by the Federal Deposit Insurance Corporation. As of December 31, 2025, the Company had an aggregate of $70.4 million invested in marketable debt securities of issuers in the banking and financial services industries. While the Company’s investment policy requires investments in highly rated securities, a wide variety of broad economic factors and issuer-specific factors could result in credit agency downgrades below the Company’s minimum credit rating requirements that could result in losses, regardless of whether the Company elects to sell the securities or hold them until maturity. To date, the Company has not experienced any credit losses or impairments of marketable debt securities due to credit rating agency downgrades.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/825/tableOfContent + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration